查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1473827

下一代避孕藥具市場 - 全球和區域分析：全球和區域分析：按性別、產品、最終用戶、地區 - 分析和預測（2024-2033）

Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 | 商品交期: 7-10個工作天內

價格
簡介目錄

該報告研究了全球下一代避孕藥市場，並提供了市場概述，包括按性別、產品、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

第1章市場：產業展望

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研發回顧
  • 監管狀況
  • 市場動態概覽

第2章 下一代避孕藥具市場（依用途）

  • 應用細分
  • 應用概述
  • 全球下一代避孕藥具市場，性別
  • 全球下一代避孕藥具市場（按最終用戶）

第3章下一代避孕藥市場，依產品類型

  • 產品細分
  • 產品概要
  • 全球下一代避孕藥具市場（按產品分類）

第4章下一代避孕藥具市場（按地區）

  • 區域概況
  • 促進因素和抑制因素
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第5章市場-競爭格局與公司概況

  • 競爭格局
  • 公司簡介
    • AbbVie
    • Bayer Corporation
    • Cooper Surgical, Inc.
    • Church & Dwight Co, Inc.
    • Merck & Co Inc.
    • Pfizer
    • Reckitt Benckiser Group Plc
    • Teva Pharmaceuticals Industries Ltd.
    • The Female Health Company/Veru Inc.
    • Afaxys, Inc
    • Aditxt
    • Dare Bioscience, Inc
    • TherapeuticsMD, Inc
    • 其他公司

第6章調查方法

簡介目錄
Product Code: BHL2050SA

This report will be delivered in 7-10 working days.

The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.

The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.

Market Segmentation

Segmentation 1: by Gender

  • Male
  • Female

Segmentation 2: by by End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels
  • Others

Segmentation 3: by Offering

  • Drugs
  • Devices

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • Latin America

Key Questions Answered:

  • What are the major market drivers, challenges, and opportunities in the global next-generation contraceptives market and their case studies?
  • How will the next-generation contraceptives market evolve and what is its scope in the future?
  • What is the market share of the leading segments and sub-segments of the global next-generation contraceptives market?
  • How will each segment of the global next-generation contraceptives market grow during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1 Markets: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
  • 1.2 Supply Chain Overview
    • 1.2.1 Value chain Analysis
    • 1.2.2 Market Map
  • 1.3 R&D Review
    • 1.3.1 Patent Filing Trend by Country, by Company
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
    • 1.5.2 Market Restraints
    • 1.5.3 Market Opportunities

2 Next-Generation Contraceptives Market by Application

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 Global Next-Generation Contraceptives Market, by Gender
    • 2.3.1 Male
    • 2.3.2 Female
  • 2.4 Global Next-Generation Contraceptives Market, by End User
    • 2.4.1 Hospital Pharmacies
    • 2.4.2 Retail Pharmacies
    • 2.4.3 Online Channels
    • 2.4.4 Others

3 Next-Generation Contraceptives Market by Product Type

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Global Next-Generation Contraceptives Market, by Offering
    • 3.3.1 Drugs
      • 3.3.1.1 Contraceptive Pills
      • 3.3.1.2 Injectables
      • 3.3.1.3 Patches
      • 3.3.1.4 Others
    • 3.3.2 Devices
      • 3.3.2.1 Condoms
      • 3.3.2.2 Vaginal Rings
      • 3.3.2.3 Intra-uterine Devices
      • 3.3.2.4 Others

4 Next-Generation Contraceptives Market by Region

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints as you go along...
  • 4.3 North America
    • 4.3.1 Markets
      • 4.3.1.1 Key Market Participants in North America
      • 4.3.1.2 Business Drivers
      • 4.3.1.3 Business Challenges
    • 4.3.2 North America Next Generation Contraceptives Market, by End User
    • 4.3.3 North America by Country
      • 4.3.3.1 U.S.
      • 4.3.3.2 Canada
  • 4.4 Europe
    • 4.4.1 Markets
      • 4.4.1.1 Key Market Participants in Europe
      • 4.4.1.2 Business Drivers
      • 4.4.1.3 Business Challenges
    • 4.4.2 Europe Next Generation Contraceptives Market, by End User
    • 4.4.3 Europe by Country
      • 4.4.3.1 U.K.
      • 4.4.3.2 Germany
      • 4.4.3.3 France
      • 4.4.3.4 Italy
      • 4.4.3.5 Spain
      • 4.4.3.6 Rest of Europe
  • 4.5 Asia-Pacific
    • 4.5.1 Markets
      • 4.5.1.1 Key Market Participants in Asia-Pacific
      • 4.5.1.2 Business Drivers
      • 4.5.1.3 Business Challenges
    • 4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
    • 4.5.3 Asia-Pacific by Country
      • 4.5.3.1 China
      • 4.5.3.2 Japan
      • 4.5.3.3 India
      • 4.5.3.4 South Korea
      • 4.5.3.5 Rest of Asia-Pacific
  • 4.6 Latin America
    • 4.6.1 Markets
      • 4.6.1.1 Key Market Participants in Latin America
      • 4.6.1.2 Business Drivers
      • 4.6.1.3 Business Challenges
    • 4.6.2 Latin America Next Generation Contraceptives Market, by End User
    • 4.6.3 Latin America by Country
      • 4.6.3.1 Brazil
      • 4.6.3.2 Mexico
      • 4.6.3.3 Rest of Latin America
  • 4.7 Middle East and Africa
    • 4.7.1 Markets
      • 4.7.1.1 Key Market Participants in Middle East and Africa
      • 4.7.1.2 Business Drivers
      • 4.7.1.3 Business Challenges
    • 4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User

5 Markets - Competitive Landscape & Company Profiles

  • 5.1 Competitive Landscape
  • 5.2 Company Profiles
    • 5.2.1 AbbVie
      • 5.2.1.1 Company Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers /End-Users
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
    • 5.2.2 Bayer Corporation
      • 5.2.2.1 Company Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers /End-Users
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
    • 5.2.3 Cooper Surgical, Inc.
      • 5.2.3.1 Company Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers /End-Users
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
    • 5.2.4 Church & Dwight Co, Inc.
      • 5.2.4.1 Company Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers /End-Users
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
    • 5.2.5 Merck & Co Inc.
      • 5.2.5.1 Company Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers /End-Users
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
    • 5.2.6 Pfizer
      • 5.2.6.1 Company Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers /End-Users
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
    • 5.2.7 Reckitt Benckiser Group Plc
      • 5.2.7.1 Company Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers /End-Users
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
    • 5.2.8 Teva Pharmaceuticals Industries Ltd.
      • 5.2.8.1 Company Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers /End-Users
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
    • 5.2.9 The Female Health Company/Veru Inc.
      • 5.2.9.1 Company Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers /End-Users
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
    • 5.2.10 Afaxys, Inc
      • 5.2.10.1 Company Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers /End-Users
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View
    • 5.2.11 Aditxt
      • 5.2.11.1 Company Overview
      • 5.2.11.2 Top Products / Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers /End-Users
      • 5.2.11.5 Key Personnel
      • 5.2.11.6 Analyst View
    • 5.2.12 Dare Bioscience, Inc
      • 5.2.12.1 Company Overview
      • 5.2.12.2 Top Products / Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers /End-Users
      • 5.2.12.5 Key Personnel
      • 5.2.12.6 Analyst View
    • 5.2.13 TherapeuticsMD, Inc
      • 5.2.13.1 Company Overview
      • 5.2.13.2 Top Products / Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Target Customers /End-Users
      • 5.2.13.5 Key Personnel
      • 5.2.13.6 Analyst View
    • 5.2.14 Other Companies

6 Research Methodology